Anti Ovary Antibody Igm Genlisa Elisa

Antibody Test Kits Hot Sale Medical Diagnostic Antigen Antibody Rapid Test Kits

- High Quality Coverall - Manufactured in South Korea *FDA Approved

COVID-19 Rapid Test Kit IgG + IgM (Colloidal Gold) comes in packs of 40 tests and contains: GCMS manufactures COVID-19 antigen test kit, the GENEDIA W COVID-19 Ag which is listed on the EU common list, also with GMP and ISO certifications. GENEDIA W COVID-19 Ag is unaffected based on the in-silicon analysis of the mutations in the nucleocapsid (N gene) of Omicron viruses. Letter of statement is available upon your request. To get over COVID-19 pandemic, especially the recent Omicron breakout, currently we are doing big promotions for three kinds of COVID-19 Ag kit. All are in stock and available right away. 1. Nasopharyngeal 2. Nasal 3. Saliva Price and Minumum Quantity Price FOB in USD: negotiable 0.8 to 1.8Minimum Order Qty: None Pieces Production Capacity: 3,000,000/monthPackaging: 20 Tests/kit, 30 Kits/box, 12 Boxes/pallet Sample: Available. Sample Cost Born By Supplier Product Model And Origin Brand: GENEDIAModel: 643G-S (Saliva) Seller Code: Genedia w covid 19 agHS Code: 3002.15 Standards: Ce Competitive Advantages Allow wider testing with fast test time (10 minutes) All necessary materials provided / no equipment needed Sensitivity: 93.33%, specificity: 100% Free sample. no moq. price is negotiable. customized packing. Other Details 20 tests / kit 24 months from the date of manufacture 2 ~ 30c(35.6 ~ 86f) available for room temperature deliver In stock. fast delivery. 1 x Instructions for Use Manual 40 x Test Cassettes 1 x Buffer 40 x Dropper

Biosensors is a medical device company known for its innovations in interventional cardiology, particularly in the field of coronary stents. The BioMatrix platform includes a range of drug-eluting stents (DES) designed to be used in the treatment of coronary artery disease. Key features of the BioMatrix stent platform, which may extend to the NeoFlex model if it's a part of the series, may include: Drug-Eluting Stent: The stents in the BioMatrix platform are drug-eluting, meaning they are coated with a medication (such as an anti-restenotic drug) designed to inhibit the regrowth of tissue inside the treated blood vessel. Biodegradable Polymer: Some versions of the BioMatrix stent use a biodegradable polymer to deliver the drug to the target site. The polymer gradually dissolves over time, leaving only the metallic stent behind. Flexible Design: The stents are designed to be flexible, allowing for easier navigation and deployment in the coronary arteries. Thin-Strut Technology: Thin struts can contribute to improved deliverability and conformability of the stent to the vessel wall. Various Sizes: The BioMatrix stent platform typically offers stents in various sizes to accommodate different patient anatomies and lesion characteristics.

the Boston Scientific Promus Elite is a coronary drug-eluting stent system. It is designed for use in patients undergoing percutaneous coronary intervention (PCI) procedures to treat coronary artery disease. Here are some key features and points related to the Boston Scientific Promus Elite coronary stent: Drug-Eluting Stent: The Promus Elite is a drug-eluting stent (DES), meaning it is coated with medication to help prevent the re-narrowing (restenosis) of the treated coronary artery. Drug Coating: The stent typically features a polymer coating containing an anti-proliferative drug. This drug is slowly released over time to inhibit the growth of tissue inside the stent, reducing the risk of restenosis. Cobalt Chromium Alloy: The stent is often made of a cobalt chromium alloy, known for its strength and flexibility. This material allows for a thin stent strut design, which can be beneficial in terms of deliverability and conformability. Delivery System: The stent is delivered to the target area using a catheter-based delivery system. The catheter is guided through the blood vessels to the site of the coronary artery lesion. Radiopaque Markers: Radiopaque markers on the stent aid in proper placement and visualization under X-ray guidance during the procedure.

Vannin Healthcare offers several effective COVID-19 tests: SGTi-flex COVID-19 IgM/IgG (25 tests per kit) STANDARD Q COVID-19 IgM/IgG Duo Test (40 tests per kit) Anti-SARS-CoV-2 Rapid Test (50 tests per kit) General Features Can detect and differentiate between IgM and IgG antibodies Convenient: no additional equipment necessary Extremely fast: results in 10-15 minutes Point-of-care testing Allow rapid decision-making in high-stakes situations Why our tests Certified: CE-IVD marked, FDA-cleared, ISO 13485, Korea GMP-certified Reliable: high clinical specificity and selectivity Easy to interpret Can detect antibodies even in asymptomatic patients Vannin Healthcare Global offers various diagnostic and serology tests for identifying the presence of Severe Acute Respiratory Syndrome Coronavirus2 (SARS-CoV-2). SARS-CoV-2 is the virus that causes COVID-19 which means that its presence could indicate that a person has been infected. There are two types of tests currently used to determine the presence of the virus: Molecular diagnostic tests or viral tests (Swab tests) Antibody serology tests (Blood tests) Vannin Healthcare Global's Serology Tests To find out whether antibodies are present in an obtained sample (whole blood, plasma, or serum), serology tests are used. The presence of antibodies could indicate a past infection. And depending on the type of the immunoglobulins present, it could also determine the approximate time when the infection occurred. After fighting a coronavirus, our bodies are likely to produce two classes of antibodies: IgM and IgG. In the case of SARS-CoV-2, both IgM and IgG are most likely to occur simultaneously within two to three weeks after a person's been infected. For a firmer diagnosis, Vannin Healthcare Global offers serology tests that check for both IgM and IgG antibodies. Can detect and differentiate between IgM and IgG antibodies Differentiating between the antibodies is crucial when it comes to providing proper medical advice to your patients. The appearance of IgM antibodies is the initial response of the organism fighting to suppress the virus. These antibodies could indicate that the patient is still infectious, and advising patients to self-isolate is the appropriate course of action. IgG antibodies can be detected in the blood sample usually within7-10 days after the onset of infection. If a patient has IgG antibodies, and no IgM antibodies, they have developed a temporary immunity to COVID-19. No additional equipment necessary The test design makes it a perfect choice for remote areas without access to fully-equipped laboratories. Simply obtain a blood sample from a patient, and add 10�µl into the appropriate place on the testing cassette along with three drops (90µl) of the buffer. The results will appear in 10-15 minutes.

Covd-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma) is a solid phase immunochromatographic assay for the rapid, qualitative and dierential detection of IgG and IgM antibodies to 2019 Novel Corona Virus in human whole blood, serum or plasma. Specification.jpg Product: Rapid Diagnostic Test Kit Item: Corona Virus Test Kit Specimen: Whole Blood/Serum/Plasma Format: Strip/Cassette Port of Loading: Shanghai OEM and ODM: OEM/ODM Welcome Shipping: By UPS, FEDEX, DHL, TNT, by air or by sea MOQ for Private label: Low MOQ 1600 boxes, Please contact us. Note: Store this product in a cool and dry place, avoid direct sunlight, stay away from places that children can contact, and avoid eye contact. If you have allergies to this product, please stop using and consult a doctor. COVID-19 Corona Virus Rapid Test Kit11.pngCOVID-19 Corona Virus Rapid Test Kit12.png